2025 Highlights & 2026 Outlook
As we step into a new year, Hervé reflects on our key achievements over the past years and outlines our strategic priorities for 2026. After a first growth phase focused on construction and structuration, we’re now entering a new chapter: one driven by diversification and continued momentum.
2025 Highlights & 2026 Outlook
A message from our CEO, Hervé Legrand, to kick off 2026
As we step into a new year, Hervé reflects on our key achievements over the past years and outlines our strategic priorities for 2026.
After a first growth phase focused on construction and structuration, we’re now entering a new chapter: one driven by diversification and continued momentum.
About Movmedix
Driven by our vision to restore infinite mobility to patients suffering from soft tissue injuries, Movmedix continues to evolve toward becoming a global leader in sports medicine. With more than three decades of expertise, we have been at the forefront of the artificial ligament field — pioneering free-fibre technology and designing implants tailored to specific clinical indications.
Building on the strong legacy of our LARS® (Ligament Advanced Reinforcement System) product range, we remain committed to developing innovative and disruptive solutions that address the evolving needs of surgeons and improve patient outcomes worldwide.
